Why Is Oncternal Therapeutics (ONCT) Stock Down 62% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Oncternal Therapeutics (ONCT) stock is falling hard on Tuesday after the company decided to end two clinical trials to switch focus.

The post Why Is Oncternal Therapeutics (ONCT) Stock Down 62% Today? appeared first on InvestorPlace.

• Buy This $5 Stock BEFORE This Apple Project Goes Live
• The Best $1 Investment You Can Make Today
• It doesn’t matter if you have $500 or $5 million. Do this now.
• Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It